InspireMD announced a proposed public offering of common stock, pre-funded warrants, and accompanying warrants to raise capital. The company plans to use the proceeds for research and development, sales, marketing, and general corporate purposes. The offering includes a 30-day option for underwriters to purchase additional shares to cover over-allotments. The offering is subject to market conditions and may not be completed as planned. InspireMD is known for its CGuard Prime carotid stent system aimed at stroke prevention.
InspireMD's proposed public offering provides context for readers interested in health-sector market activity. For readers following health-sector stocks on Pluang, here is the market snapshot as of Nov 13, 2026 04:11 WIB: out of 150 priced US health stocks, 23 rose and 124 fell. Notable movers include MRNA (Moderna, Inc.) at USD 230.95 with a 1-day change of -7.13% and a typical hold time on Pluang of 58 days, BFLY (Butterfly Network Inc. Class A Common Stock) at USD 6.64 down 7.00%, and RXRX (Recursion Pharmaceuticals Inc) at USD 3.34 down 6.96% with a balanced Pluang order activity of 50% Sell and 50% Buy.
Super League Enterprise, a company specializing in audience intelligence and media activation for the gaming industry, announced it will release its financial results for the third quarter ending September 30, 2026, on November 16, 2026, after market...
Stantec Inc. reported a 9.4% increase in net revenue to $1.9 billion for Q3 2026, driven by organic and acquisition growth. Adjusted EBITDA rose 16.6% to $377.1 million with a record margin of 20.2%, while adjusted EPS grew 23.5% to $1.89. The compan...
Siemens reported earnings per share of $1.62 and revenue of $26.28 billion, both exceeding analyst expectations. The company saw record orders and double-digit revenue growth in its smart infrastructure and digital industries units, prompting it to r...
ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...
The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...
